Who owns BIO-TECHNE Corp?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TECH from SEC Form 13F filings across 583 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 583 institutions disclosed 155.6M shares of BIO-TECHNE Corp worth $11.27B — about 99.2% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
583
13F holders
$11.27B
value, 2026 filers
99.2%
of shares outstanding (155.6M sh)
97
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of TECH's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 14.3M | $1.03B | 0.0% | 9.1% | +1.6% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 10.3M | $742.9M | 0.0% | 6.5% | +0.3% |
| 3 | HBK INVESTMENTS L P | 7.7M | $560.3M | 5.8% | 4.9% | +13.3% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 6.3M | $460.1M | 0.0% | 4% | -2.4% |
| 5 | FIL Ltd | 6.3M | $454.6M | 0.3% | 4% | +158783.7% |
| 6 | STATE STREET CORP | 6.0M | $438.1M | 0.0% | 3.9% | +1.1% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 5.4M | $393.1M | 0.0% | 3.5% | +1.5% |
| 8 | GOLDMAN SACHS GROUP INC | 4.1M | $300.3M | 0.0% | 2.6% | -43.6% |
| 9 | MILLENNIUM MANAGEMENT LLC | 4.1M | $296.5M | 0.1% | 2.6% | +313.7% |
| 10 | Invesco Ltd. | 3.8M | $273.6M | 0.0% | 2.4% | -24.3% |
| 11 | Balyasny Asset Management L.P. | 3.4M | $246.7M | 0.3% | 2.2% | +306.7% |
| 12 | Ruane, Cunniff & Goldfarb L.P. | 3.3M | $242.3M | 3.9% | 2.1% | -0.2% |
| 13 | MORGAN STANLEY | 3.3M | $241.3M | 0.0% | 2.1% | -47.8% |
| 14 | WHITEBOX ADVISORS LLC | 2.6M | $190.1M | 2.2% | 1.7% | +24.9% |
| 15 | D. E. Shaw & Co., Inc. | 2.5M | $183.5M | 0.1% | 1.6% | +1008.0% |
| 16 | UBS Group AG | 2.5M | $180.6M | 0.0% | 1.6% | +0.6% |
| 17 | Qube Research & Technologies LtdNEW | 2.4M | $172.4M | 0.1% | 1.5% | new |
| 18 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 2.3M | $168.2M | 0.1% | 1.5% | -15.5% |
| 19 | NEUBERGER BERMAN GROUP LLC | 2.3M | $163.6M | 0.1% | 1.4% | -20.6% |
| 20 | BARCLAYS PLC | 2.3M | $163.1M | 0.0% | 1.4% | +937.0% |
| 21 | CITIGROUP INC | 1.8M | $127.6M | 0.0% | 1.1% | +295.5% |
| 22 | JPMORGAN CHASE & CO | 1.7M | $123.1M | 0.0% | 1.1% | -9.2% |
| 23 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.7M | $121.7M | 0.0% | 1.1% | +3.5% |
| 24 | MAVERICK CAPITAL LTD | 1.5M | $111.3M | 0.9% | 1% | 0.0% |
| 25 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.4M | $99.6M | 0.0% | 0.9% | +458.7% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.